Not yet recruitingInterventionalNot ApplicableUpdated Aug 11, 2026
Clinical Study of CT 5400 RT for System Validation | NCT06466577 | Trialant
CompletedInterventionalNot ApplicableUpdated Jun 13, 2025
Clinical Study of CT 5400 RT for System Validation
Clinical Study of CT 5400 RT for System Validation
ClinicalTrials.gov ID
NCT06466577
Lead Sponsor
Philips Clinical & Medical Affairs GlobalINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
36Actual
Last Update Posted
Jun 13, 2025Actual
Start Date
Jan 17, 2025Actual
Primary Completion Date
Jan 25, 2025Actual
Completion Date
Feb 20, 2025Actual
Official Title
Clinical Study of CT 5400 RT for System Validation
Brief Summary
The purpose of this clinical trial is to evaluate the efficacy and safety of the CT 5400 RT System.
Performance and Safety
CT 5400 RT System
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
18≤ Age ≤ 75 years old;
Subjects with Clear consciousness; Subjects can cooperate and act autonomously;
Subjects agree to participate in this clinical study and sign the subject's informed consent;
Women subjects of childbearing age should have a negative pregnancy test and should have no plans to become pregnant in the next 6 months.
Exclusion Criteria:
Subjects who do not have full capacity for civil conduct;
Women subjects who are pregnant or in lactating phase;
Subjects who have had a CT scan within one year;
Subjects with a history of allergies or asthma, severe hepatic and renal insufficiency or hyperthyroidism in which are considered as contraindication for CT contrast-enhanced examination;
According to the opinion of the investigator: any situation that may affect the evaluation of the results or expose subjects into health risk;
Subjects with mental disorders who cannot cooperate with the examination